Outcomes of standard versus CYP3A5 genotype adapted dosing of Tacrolimus in renal transplant recipients: A randomized control study.

被引：0
|
作者：
Goel, Vivek [1 ]
Malik, Manish [2 ]
Bhalla, A. K. [3 ]
机构：
[1] Apollo Multispecialty Hosp, Nephrol, Kolkata, India
[2] Sir Ganga Ram Hosp, Nephrol, New Delhi, India
[3] Sir Ganga Ram Hosp, Nephrol, New Delhi, India
来源：
TRANSPLANTATION | 2024年 / 108卷 / 9S期
关键词：
D O I：
10.1097/01.tp.0001065280.60236.aa
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
305.7
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Outcomes of standard versus CYP3A5 genotype adapted dosing of Tacrolimus in renal transplant recipients: A randomized control study.
    Goel, Vivek
    Malik, Manish
    Bhalla, A. K.
    TRANSPLANTATION, 2024, 108 (09) : 181 - 181
  • [2] Influence of CYP3A5 Polymorphisms on Tacrolimus Dosing in Renal Transplant Recipients
    Kotha, Chandini
    Sahay, Manisha
    TRANSPLANTATION, 2022, 106 (09) : S135 - S135
  • [3] CYP3A5 Polymorphism in Mexican Renal Transplant Recipients and its Association with Tacrolimus Dosing
    Garcia-Roca, Pilar
    Medeiros, Mara
    Reyes, Herlinda
    Antonio Rodriguez-Espino, Benjamin
    Alberu, Josefina
    Ortiz, Lourdes
    Vasquez-Perdomo, Mayela
    Elizondo, Guillermo
    Eduardo Morales-Buenrostro, Luis
    Mancilla Urrea, Eduardo
    Castaneda-Hernandez, Gilberto
    ARCHIVES OF MEDICAL RESEARCH, 2012, 43 (04) : 283 - 287
  • [4] Impact of CYP3A5 Genotype on Tacrolimus Dosing Requirements and Trough Concentrations in Cardiac Transplant Recipients
    Wu, Yanting
    Eadon, Michael T.
    Schenkelberg, Laurie
    Rao, Roopa A.
    Skaar, Todd C.
    Tillman, Emma M.
    Shugg, Tyler A.
    PHARMACOGENETICS AND GENOMICS, 2025, 35 (01): : 20 - 20
  • [5] CYP3A5 GENOTYPE AND TACROLIMUS DOSING REQUIREMENTS IN RENAL TRANSPLANT. CASE REPORT.
    Belen Martinez-lopez, Ana
    Blanco, Olalla Alvarez
    Lopez-fernandez, Luis A.
    Fernandez-llamazares, Cecilia M.
    Manrique-rodriguez, Silvia
    Barraca Nunez, Daniel
    Luque De Pablos, Augusto
    PEDIATRIC NEPHROLOGY, 2015, 30 (09) : 1726 - 1726
  • [6] Age and CYP3A5 genotype affect tacrolimus dosing requirements after transplant in pediatric heart recipients
    Gijsen, Violette
    Mital, Seema
    van Schaik, Ron H.
    Soldin, Offie P.
    Soldin, Steven J.
    van der Heiden, Ilse P.
    Nulman, Irena
    Koren, Gideon
    de Wildt, Saskia N.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (12): : 1352 - 1359
  • [7] CYP3A5 Genotype Had no Impact on Intrapatient Variability of Tacrolimus Clearance in Renal Transplant Recipients
    Spierings, N.
    Holt, D. W.
    MacPhee, Iain A. M.
    THERAPEUTIC DRUG MONITORING, 2013, 35 (03) : 328 - 331
  • [8] THE ASSOCIATION OF BODYWEIGHT AND CYP3A5 GENOTYPE WITH TACROLIMUS TROUGH LEVEL IN CHINESE RENAL TRANSPLANT RECIPIENTS
    Tang, Jang-Tao
    Shi, Yun-Ying
    Li, Yi
    Yan, Lin
    Wang, Ting-Li
    Bai, Yang-Juan
    Zou, Yuan-Gao
    Tao, Ye
    Wang, Lan-Lan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 415 - 416
  • [9] Effect of CYP3A5 Genotype on Renal Allograft Recipients Treated With Tacrolimus
    Chen, J. S.
    Li, L. S.
    Cheng, D. R.
    Ji, S. M.
    Sun, Q. Q.
    Cheng, Z.
    Wen, J. Q.
    Sha, G. Z.
    Liu, Z. H.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (05) : 1557 - 1561
  • [10] Prediction of Tacrolimus Drug Dosing and Metabolism based on CYP3A5 Polymorphism in Indian Renal Transplant Recipients
    Patel, Mohan
    Goswami, Jitendra
    Balwani, Manish
    Gumber, Manoj
    TRANSPLANTATION, 2018, 102 : S92 - S92
12345